Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.05 USD | +0.25% | +0.72% | +51.69% |
06-18 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
06-18 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CALTX Stock
- CALT Stock
- Revisions Calliditas Therapeutics AB